Comprehensive approaches for the detection of Burkholderia pseudomallei and diagnosis of melioidosis in human and environmental samples.
Burkholderia pseudomallei
Diagnosis
Melioidosis
Molecular tools
Vaccine
Virulence mechanism
Journal
Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
11
09
2021
revised:
06
06
2022
accepted:
10
06
2022
pubmed:
17
6
2022
medline:
10
8
2022
entrez:
16
6
2022
Statut:
ppublish
Résumé
Melioidosis is endemic in Southeast Asia and northern Australia. The causative agent of melioidosis is a Gram-negative bacterium, Burkholderia pseudomallei. Its invasion can be fatal if melioidosis is not treated promptly. It is intrinsically resistant to a variety of antibiotics. In this paper, we present a comprehensive overview of the current trends on melioidosis cases, treatments, B. pseudomallei virulence factors, and molecular techniques to detect the bacterium from different samples. The clinical and microbial diagnosis methods of identification and detection of B. pseudomallei are commonly used for the rapid diagnosis and typing of strains, such as polymerase chain reaction or multi-locus sequence typing. The genotyping strategies and techniques have been constantly evolving to identify genomic loci linked to or associated with this human disease. More research strategies for detecting and controlling melioidosis should be encouraged and conducted to understand the current situation. In conclusion, we review existing diagnostic methodologies for melioidosis detection and provide insights on prospective diagnostic methods for the bacterium.
Identifiants
pubmed: 35710088
pii: S0882-4010(22)00250-9
doi: 10.1016/j.micpath.2022.105637
pii:
doi:
Substances chimiques
Virulence Factors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105637Informations de copyright
Copyright © 2022. Published by Elsevier Ltd.